[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339118-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339118-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","evaluating-offspring-genomic-and-epigenomic-alterations-after-prenatal-exposure-to-cancer-treatment-in-pregnancy-ge-cip-a-multicentric-observational-study","Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment in Pregnancy (GE-CIP) - a multicentric observational study","","Examines whether prenatal exposure to cancer treatment may induce genomic and/or epigenomic alterations in offspring with potential long-term consequences. Around 1 in 1000–2000 pregnancies involve a cancer diagnosis; chemotherapy is reassuring for short-term outcomes but subtle differences have been observed. A multicentric observational design collects multiple biological samples at birth and follow-up, comparing chemotherapy-treated and non-treated cancer pregnancies plus healthy controls. Results will be disseminated through conferences, open-access publications, and patient-focused channels.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/evaluating-offspring-genomic-and-epigenomic-alterations-after-prenatal-exposure-to-cancer-treatment-in-pregnancy-ge-cip-a-multicentric-observational-study/339118/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/evaluating-offspring-genomic-and-epigenomic-alterations-after-prenatal-exposure-to-cancer-treatment-in-pregnancy-ge-cip-a-multicentric-observational-study/339118.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the GE-CIP study?","Question",{"text":63,"@type":64},"To collect and compare genomic and epigenomic changes in offspring after prenatal exposure to cancer treatment, assessing potential newborn alterations across multiple sample types and time points.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which participant groups are compared in this observational study?",{"text":68,"@type":64},"Chemotherapy-treated pregnant patients with cancer, pregnant patients with cancer not treated with chemotherapy, and healthy pregnant women.",{"name":70,"@type":61,"acceptedAnswer":71},"What sample types and methods are used to evaluate genomic and epigenomic alterations?",{"text":72,"@type":64},"Cord blood, meconium, and neonatal buccal cells are collected at birth, with additional blood, buccal cells, and urine at 6, 18 and/or 36 months. Bulk and single-cell approaches identify genetic variants and DNA-methylation changes, while mass spectrometry assesses fetal exposure and biological effective dose in meconium and cord blood.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339118,1790790938,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Open access Protocol  \n Evaluating offspring Genomic and  \nEpigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study  \nIlana Struys  ,1 Carolina Velázquez,1 Koenraad Devriendt,2 Lode Godderis,3,4 Heidi Segers,5 Bernard Thienpont,6 Ruben van Boxtel,7 Kristel Van Calsteren,8 Thierry Voet,6,9 Vera Wolters,10 Liesbeth Lenaerts,1 Frederic Amant1,8,10  \nTo cite: Struys I, Velázquez C, Devriendt K, et al. Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy  \n(GE-CIP): a multicentric observational study. BMJ Open 2024;14:e081833 . doi:10 . 1136/ bmjopen-2023-081833  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2023-081833](bmjopen-2023-081833)) .  \nReceived 07 November 2023 Accepted 05 March 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nProfessor Frederic Amant; [frederic.amant@uzleuven.be](frederic.amant@uzleuven.be)  \nABSTRACT  \nIntroduction Around 1 in 1000–2000 pregnancies are affected by a cancer diagnosis. Previous studies have shown that chemotherapy during pregnancy has reassuring cognitive and cardiac neonatal outcomes, and hence has been proposed as standard of care. However, although these children perform within normal ranges for their age, subtle differences have been identified. Given that chemotherapeutic compounds can cross the placenta, the possibility that prenatal chemotherapy exposure mutates the offspring’s genome and/or epigenome, with potential deleterious effects later in life, urges to be investigated.  \nMethods and analyses This multicentric observational study aims to collect cord blood, meconium and neonatal buccal cells at birth, as well as peripheral blood, buccal cells and urine from infants when 6, 18 and/or 36 months of age. Using bulk and single-cell approaches, we will compare samples from chemotherapy-treated pregnant patients with cancer, pregnant patients with cancer not treated with chemotherapy and healthy pregnant women. Potential chemotherapy-related newborn genomic and/ or epigenomic alterations, such as single nucleotide variants, copy number variants and DNA-methylation alterations, will be identified in mononuclear and epithelial cells, isolated from blood, buccal swabs and urine. DNA from maternal peripheral blood and paternal buccal cells will be used to determine de novo somatic mutations in the neonatal blood and epithelial cells. Additionally, the accumulated exposure of the fetus, and biological effective dose of alkylating agents, will be assessed in meconiumand cord blood via mass spectrometry approaches.  \nEthics and dissemination The Ethics Committee Research of UZ/KU Leuven (EC Research) and the Medical Ethical Review Committee of University Medical Center Amsterdam have approved the study. Results of this study will be disseminated via presentations at (inter) national conferences, through peer-reviewed, open-access publications, via social media platforms aimed to inform patients and healthcare workers, and through the website of the International Network on Cancer, Infertility and Pregnancy ([www.cancerinpregn](www.cancerinpregnancy.org)[ancy.org](www.cancerinpregnancy.org)).  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ In this study, the mutational consequences of prenatal chemotherapy exposure in newborn DNA will be investigated using a variety of innovative bulk and single-cell techniques, allowing a comprehensive assessment of different types of genetic and epigenetic aberrations.  \n⇒ Different tissue types will be investigated, that is, cord blood and buccal epithelial cells, wh","cbCaia8ZaJxDWQmH","https://ap.wps.com/l/cbCaia8ZaJxDWQmH","pdf",661712,"English","# Abstract\n## Introduction\n## Methods and analyses\n## Ethics and dissemination\n## Strengths and limitations of this study\n# Introduction","[{\"question\":\"What is the main objective of the GE-CIP study?\",\"answer\":\"To collect and compare genomic and epigenomic changes in offspring after prenatal exposure to cancer treatment, assessing potential newborn alterations across multiple sample types and time points.\"},{\"question\":\"Which participant groups are compared in this observational study?\",\"answer\":\"Chemotherapy-treated pregnant patients with cancer, pregnant patients with cancer not treated with chemotherapy, and healthy pregnant women.\"},{\"question\":\"What sample types and methods are used to evaluate genomic and epigenomic alterations?\",\"answer\":\"Cord blood, meconium, and neonatal buccal cells are collected at birth, with additional blood, buccal cells, and urine at 6, 18 and/or 36 months. Bulk and single-cell approaches identify genetic variants and DNA-methylation changes, while mass spectrometry assesses fetal exposure and biological effective dose in meconium and cord blood.\"}]","Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment in Pregnancy (GE-CIP) - a multicentric observational study | PDF",1790028011,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6d9ebb7d01c5467c227b3355440df24.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/461e2526e610bcfe2c6769a3ff52029d.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04343546f3b23b140c82cfb59c97ba9a.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f89a0fe945891fc9d9fc49486c527b4b.webp",980,1306]